Ειδοποίηση Μελετητή:[ intitle:Bioprinting ]
Mass customisation governance: regulation, liability, and intellectual property of re-distributed manufacturing in 3D bioprinting
P Li, A Faulkner - 2017
The feasibility study assesses the impacts of existing legal regimes on re-distributed
manufacturing (RDM) in 3D bioprinting (bio-3DP). It investigates the viability of an
embedded watermarking system into mass customisation governance of RDM as part of the
manufacturing (RDM) in 3D bioprinting (bio-3DP). It investigates the viability of an
embedded watermarking system into mass customisation governance of RDM as part of the
 |  |  |
[HTML] Microfluidic-enhanced 3D bioprinting of aligned myoblast-laden hydrogels leads to functionally organized myofibers in vitro and in vivo
M Costantini, S Testa, P Mozetic, A Barbetta, C Fuoco… - Biomaterials, 2017
Abstract We present a new strategy for the fabrication of artificial skeletal muscle tissue with
functional morphologies based on an innovative 3D bioprinting approach. The methodology
is based on a microfluidic printing head coupled to a co-axial needle extruder for high-
functional morphologies based on an innovative 3D bioprinting approach. The methodology
is based on a microfluidic printing head coupled to a co-axial needle extruder for high-
| | |
3D Bioprinting from the Micrometer to Millimeter Length Scales: Size Does Matter
TJ Hinton, A Lee, AW Feinberg - Current Opinion in Biomedical Engineering, 2017
Abstract 3D bioprinting has rapidly expanded from a niche technology and in to a versatile
platform for fabricating tissues with complex geometries and features ranging from the
cellular to organ length scales. Recent advances include the development of yield-stress
platform for fabricating tissues with complex geometries and features ranging from the
cellular to organ length scales. Recent advances include the development of yield-stress
| | |
[PDF] 3D bioprinting regulations: a UK/EU perspective
P Li, A Faulkner - European Journal of Risk Regulation, 2017
This section introduces the challenges 3D bioprinting poses to the existing legal regime
across bioethics, safety, regenerative medicine, and tissue engineering. We briefly review
the 3D bioprinting technology and look into the relevant regulatory instruments for the pre-
across bioethics, safety, regenerative medicine, and tissue engineering. We briefly review
the 3D bioprinting technology and look into the relevant regulatory instruments for the pre-
| | |
[PDF] Luser-assisted bioprinting to deal with tissue complexity in regenerative
JC Fricain, M Rémy, R Bareille
Laser-assisted bioprinting is one among several technologies that are being developed in
the recent and growing field of bioprinting. Bioprinting is defined as the use of
computeraided transfer processes for patterning and assembling living and non-living
the recent and growing field of bioprinting. Bioprinting is defined as the use of
computeraided transfer processes for patterning and assembling living and non-living
| | |
Αυτή η Ειδοποίηση του Μελετητή Google σας προσφέρεται από τη Google
Ακύρωση ειδοποίησης
Δημιουργία λίστας των ειδοποιήσεών μου
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου